Gianluca Trifirò

11.6k total citations · 1 hit paper
270 papers, 7.0k citations indexed

About

Gianluca Trifirò is a scholar working on Economics and Econometrics, Toxicology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Gianluca Trifirò has authored 270 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Economics and Econometrics, 51 papers in Toxicology and 36 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Gianluca Trifirò's work include Pharmacovigilance and Adverse Drug Reactions (51 papers), Health Systems, Economic Evaluations, Quality of Life (37 papers) and Pharmaceutical Economics and Policy (29 papers). Gianluca Trifirò is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (51 papers), Health Systems, Economic Evaluations, Quality of Life (37 papers) and Pharmaceutical Economics and Policy (29 papers). Gianluca Trifirò collaborates with scholars based in Italy, Netherlands and United States. Gianluca Trifirò's co-authors include Janet Sultana, Miriam Sturkenboom, Edoardo Spina, Paola Maria Cutroneo, Giampiero Mazzaglia, Achille P. Caputi, Salvatore Crisafulli, Preciosa M. Coloma, Martijn J. Schuemie and Johan van der Lei and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Annals of Internal Medicine.

In The Last Decade

Gianluca Trifirò

258 papers receiving 6.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical and economic burden of adverse drug reactions

2013 377 citations Janet Sultana, Paola Maria Cutroneo et al. profile →

Peers

Countries citing papers authored by Gianluca Trifirò

Since Specialization

Citations

This map shows the geographic impact of Gianluca Trifirò's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianluca Trifirò with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianluca Trifirò more than expected).

Fields of papers citing papers by Gianluca Trifirò

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gianluca Trifirò. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianluca Trifirò. The network helps show where Gianluca Trifirò may publish in the future.

Co-authorship network of co-authors of Gianluca Trifirò

This figure shows the co-authorship network connecting the top 25 collaborators of Gianluca Trifirò. A scholar is included among the top collaborators of Gianluca Trifirò based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gianluca Trifirò. Gianluca Trifirò is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative Gastrointestinal Safety of Dulaglutide, Semaglutide, and Tirzepatide in Adults With Type 2 Diabetes 2025 ·Annals of Internal Medicine ·Salvatore Crisafulli, Wajd Alkabbani, Julie M. Paik, Katsiaryna Bykov, Ali Tavakkoli, Robert J. Glynn, (unknown), Elaine W Yu, Gianluca Trifirò, Deborah J. Wexler, Elisabetta Patorno	0
2	Agreement of Different Drug-Drug Interaction Checkers for Proton Pump Inhibitors 2024 ·JAMA Network Open ·(unknown), Salvatore Crisafulli, (unknown), Luca Piccoli, Luca L’Abbate, Gianluca Trifirò	2
3	Pharmacological Therapies of Spinal Muscular Atrophy: A Narrative Review of Preclinical, Clinical–Experimental, and Real-World Evidence 2023 ·Brain Sciences ·Salvatore Crisafulli, (unknown), (unknown), Gianluca Trifirò, Annamaria De Luca	10
4	Exploring the Use of Monoclonal Antibodies and Antiviral Therapies for Early Treatment of COVID-19 Outpatients in a Real-World Setting: A Nationwide Study from England and Italy 2023 ·BioDrugs ·(unknown), Nicoletta Luxi, (unknown), (unknown), Pasquale De Nardo, Alessia Savoldi, Alison Yeomans, Mariam Molokhia, Evelina Tacconelli, Gianluca Trifirò	2
5	Testing of Coding Algorithms for Inflammatory Bowel Disease Identification, as Indication for Use of Biological Drugs, Using a Claims Database from Southern Italy 2023 ·Clinical Epidemiology ·Ylenia Ingrasciotta, Valentina Isgrò, (unknown), Valentina Ientile, Andrea Fontana, Luca L’Abbate, Roberto Benoni, (unknown), Michele Tari, Angela Alibrandi, Gianluca Trifirò	2
6	An overview of methodological flaws of real-world studies investigating drug safety in the post-marketing setting 2023 ·Expert Opinion on Drug Safety ·Salvatore Crisafulli, Zakir Khan, Yusuf Karataş, Marco Tuccori, Gianluca Trifirò	9
7	Il ruolo della real-world evidence nello studio dell’epidemiologia delle malattie rare e nella valutazione post-marketing dei farmaci orfani 2022 ·Recenti Progressi in Medicina ·Salvatore Crisafulli, Gianluca Trifirò	2
8	Global epidemiology of acromegaly: a systematic review and meta-analysis 2021 ·European Journal of Endocrinology ·Salvatore Crisafulli, Nicoletta Luxi, Janet Sultana, Andrea Fontana, (unknown), G Giuffrida, Francesco Ferraù, Daniele Gianfrilli, Alessia Cozzolino, Maria Cristina De Martino, Federico Gatto, Francesco Barone‐Adesi, Salvatore Cannavò, Gianluca Trifirò	53
9	Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study 2021 ·Vaccines ·Marco Massari, Stefania Spila Alegiani, Massimo Fabiani, Valeria Belleudi, Gianluca Trifirò, Ursula Kirchmayer, (unknown), Pamela Mancuso, Francesca Menniti‐Ippolito, Rosa Gini, Claudia Bartolini, Olivia Leoni, (unknown), (unknown), Stefano Guzzinati, Nicoletta Luxi, Flavia Riccardo, Paolo Giorgi Rossi	10
10	Comparison of Direct Oral Anticoagulant Use for the Treatment of Non-Valvular Atrial Fibrillation in Pivotal Clinical Trials vs. the Real-World Setting: A Population-Based Study from Southern Italy 2021 ·Pharmaceuticals ·Ylenia Ingrasciotta, Andrea Fontana, (unknown), Valentina Ientile, Janet Sultana, (unknown), (unknown), Paolo Calabrò, Giuseppe Andò, Gianluca Trifirò	1
11	Direct healthcare costs of chronic kidney disease management in Italy: What cost‐savings can be achieved with higher biosimilar uptake and more appropriate use of erythropoiesis‐stimulating agents? 2020 ·Pharmacoepidemiology and Drug Safety ·Ylenia Ingrasciotta, Janet Sultana, (unknown), Valentina Ientile, (unknown), Alessandro Chinellato, Daniele Ugo Tari, Rosa Gini, (unknown), Salvatore Scondotto, (unknown), Giuseppe Traversa, Mariangela Rossi, Domenico Santoro, Gianluca Trifirò, (unknown)	4
12	Management of cancer-associated anemia with erythropoiesis-stimulating agents: ASCO/ASH clinical practice guideline update 2019 ·Blood Advances ·Julia Bohlius, Kari Bohlke, Roberto Castelli, Benjamin Djulbegović, Maryam B. Lustberg, Massimo Martino, Giannis Mountzios, Namrata Peswani, Laura Porter, Tiffany Tanaka, Gianluca Trifirò, Hushan Yang, Alejandro Lazo‐Langner	112
13	Identifying Data Elements to Measure Frailty in a Dutch Nationwide Electronic Medical Record Database for Use in Postmarketing Safety Evaluation: An Exploratory Study 2019 ·Drug Safety ·Janet Sultana, (unknown), Marcel de Wilde, Maria de Ridder, Johan van der Lei, Miriam Sturkenboom, Gianluca Trifirò	4
14	Healthcare Database Networks for Drug Regulatory Policies: International Workshop on the Canadian, US and Spanish Experience and Future Steps for Italy 2019 ·Drug Safety ·Janet Sultana, Francesco Trotta, Antonio Addis, Jeffrey S. Brown, Miguel Gil, Francesca Menniti‐Ippolito, (unknown), Samy Suissa, Gianluca Trifirò	12
15	Analgesic drug use in elderly persons: A population-based study in Southern Italy 2019 ·PLoS ONE ·Ylenia Ingrasciotta, Janet Sultana, Francesco Giorgianni, Enrica Menditto, Angelo Scuteri, Michele Tari, Daniele Ugo Tari, Giorgio Basile, Gianluca Trifirò	16
16	Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives 2018 ·Drug Safety ·Janet Sultana, Ugo Moretti, Antonio Addis, (unknown), Annalisa Capuano, A. Kant, Joan‐Ramon Laporte, Marie Lindquist, June Raine, Daniele Sartori, Gianluca Trifirò, Marco Tuccori, Mauro Venegoni, Eugène van Puijenbroek, Roberto Leone	6
17	The economic burden of preventable adverse drug reactions: a systematic review of observational studies 2018 ·Expert Opinion on Drug Safety ·(unknown), Janet Sultana, Paola Maria Cutroneo, (unknown), (unknown), Salvatore Crisafulli, Ylenia Ingrasciotta, Francesco Salvo, Edoardo Spina, Gianluca Trifirò	136
18	Biological substantiation of antipsychotic-associated pneumonia: Systematic literature review and computational analyses 2017 ·PLoS ONE ·Janet Sultana, Marco Calabrò, Ricard García-Serna, Carmen Ferrajolo, Concetta Crisafulli, Jordi Mestres, Gianluca Trifirò	20
19	Can information on functional and cognitive status improve short-term mortality risk prediction among community-dwelling older people? A cohort study using a UK primary care database 2017 ·Clinical Epidemiology ·Janet Sultana, Andrea Fontana, Francesco Giorgianni, Giorgio Basile, Elisabetta Patorno, Alberto Pilotto, Mariam Molokhia, Robert Stewart, Miriam Sturkenboom, Gianluca Trifirò	10
20	Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease 2014 ·BioMed Research International ·Gianluca Trifirò, Janet Sultana, Francesco Giorgianni, Ylenia Ingrasciotta, Michele Buemi, (unknown), Daniele Ugo Tari, (unknown), (unknown), Vincenzo Arcoraci, Domenico Santoro	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact